A phase 1b study of IMU-131 her2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

M. Maglakelidze, T. Yau, I. Bulat, C. Yen, Y. Chao, L. Bai, A. Good, N. Ede, L. Chong, S. Tanasanvimon, C. Charoetum, H. Loong, W. Lausoontornsiri, W. Arpornwirat, J. Maneechavakajon, T. Ungtrakul, W. Chou

研究成果: Article同行評審

原文English
頁(從 - 到)iv123
期刊Annals of Oncology
30
DOIs
出版狀態Published - 2019 七月

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

引用此